FMP
AnPac Bio-Medical Science Co., Ltd.
ANPC
NASDAQ
Inactive Equity
AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.
4.3 USD
-0.14 (-3.26%)
About
ceo
Dr. Chris Chang Yu
sector
Healthcare
industry
Biotechnology
website
https://www.anpacbio.comexchange
NASDAQ
Description
AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.
CIK
0001786511
ISIN
US03635R2067
CUSIP
03635R107
Address
801 Bixing Street
Phone
86 57 8205 1666
Country
CN
Employee
89
IPO Date
Jan 30, 2020
Key Executives
